Imaging of glutamate in the spinal cord using GluCEST

Feliks Kogan, Anup Singh, Catherine Debrosse, Mohammad Haris, Kejia Cai, Ravi Prakash Nanga, Mark Elliott, Hari Hariharan, Ravinder Reddy

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Glutamate (Glu) is the most abundant excitatory neurotransmitter in the brain and spinal cord. The concentration of Glu is altered in a range of neurologic disorders that affect the spinal cord including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and spinal cord injury. Currently available magnetic resonance spectroscopy (MRS) methods for measuring Glu are limited to low spatial resolution, which makes it difficult to measure differences in gray and white matter glutamate. Recently, it has been shown that Glu exhibits a concentration dependent chemical exchange saturation transfer (CEST) effect between its amine (-NH2) group protons and bulk water protons (GluCEST). Here, we demonstrate the feasibility of imaging glutamate in the spinal cord at 7T using the GluCEST technique. Results from healthy human volunteers (N=7) showed a significantly higher (p<0.001) GluCESTasym from gray matter (6.6±0.3%) compared to white matter (4.8±0.4%). Potential overlap of CEST signals from other spinal cord metabolites with the observed GluCESTasym is discussed. This noninvasive approach potentially opens the way to image Glu in vivo in the spinal cord and to monitor its alteration in many disease conditions.

Original languageEnglish
Pages (from-to)262-267
Number of pages6
JournalNeuroImage
Volume77
DOIs
Publication statusPublished - 15 Aug 2013
Externally publishedYes

Fingerprint

Glutamic Acid
Spinal Cord
Protons
Amyotrophic Lateral Sclerosis
Nervous System Diseases
Spinal Cord Injuries
Multiple Sclerosis
Amines
Neurotransmitter Agents
Healthy Volunteers
Magnetic Resonance Spectroscopy
Water
Brain

Keywords

  • Chemical exchange saturation transfer
  • Glutamate
  • MRI
  • Spinal cord

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Neurology

Cite this

Kogan, F., Singh, A., Debrosse, C., Haris, M., Cai, K., Nanga, R. P., ... Reddy, R. (2013). Imaging of glutamate in the spinal cord using GluCEST. NeuroImage, 77, 262-267. https://doi.org/10.1016/j.neuroimage.2013.03.072

Imaging of glutamate in the spinal cord using GluCEST. / Kogan, Feliks; Singh, Anup; Debrosse, Catherine; Haris, Mohammad; Cai, Kejia; Nanga, Ravi Prakash; Elliott, Mark; Hariharan, Hari; Reddy, Ravinder.

In: NeuroImage, Vol. 77, 15.08.2013, p. 262-267.

Research output: Contribution to journalArticle

Kogan, F, Singh, A, Debrosse, C, Haris, M, Cai, K, Nanga, RP, Elliott, M, Hariharan, H & Reddy, R 2013, 'Imaging of glutamate in the spinal cord using GluCEST', NeuroImage, vol. 77, pp. 262-267. https://doi.org/10.1016/j.neuroimage.2013.03.072
Kogan F, Singh A, Debrosse C, Haris M, Cai K, Nanga RP et al. Imaging of glutamate in the spinal cord using GluCEST. NeuroImage. 2013 Aug 15;77:262-267. https://doi.org/10.1016/j.neuroimage.2013.03.072
Kogan, Feliks ; Singh, Anup ; Debrosse, Catherine ; Haris, Mohammad ; Cai, Kejia ; Nanga, Ravi Prakash ; Elliott, Mark ; Hariharan, Hari ; Reddy, Ravinder. / Imaging of glutamate in the spinal cord using GluCEST. In: NeuroImage. 2013 ; Vol. 77. pp. 262-267.
@article{2e3d5d28547d47218e3768643e77c817,
title = "Imaging of glutamate in the spinal cord using GluCEST",
abstract = "Glutamate (Glu) is the most abundant excitatory neurotransmitter in the brain and spinal cord. The concentration of Glu is altered in a range of neurologic disorders that affect the spinal cord including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and spinal cord injury. Currently available magnetic resonance spectroscopy (MRS) methods for measuring Glu are limited to low spatial resolution, which makes it difficult to measure differences in gray and white matter glutamate. Recently, it has been shown that Glu exhibits a concentration dependent chemical exchange saturation transfer (CEST) effect between its amine (-NH2) group protons and bulk water protons (GluCEST). Here, we demonstrate the feasibility of imaging glutamate in the spinal cord at 7T using the GluCEST technique. Results from healthy human volunteers (N=7) showed a significantly higher (p<0.001) GluCESTasym from gray matter (6.6±0.3{\%}) compared to white matter (4.8±0.4{\%}). Potential overlap of CEST signals from other spinal cord metabolites with the observed GluCESTasym is discussed. This noninvasive approach potentially opens the way to image Glu in vivo in the spinal cord and to monitor its alteration in many disease conditions.",
keywords = "Chemical exchange saturation transfer, Glutamate, MRI, Spinal cord",
author = "Feliks Kogan and Anup Singh and Catherine Debrosse and Mohammad Haris and Kejia Cai and Nanga, {Ravi Prakash} and Mark Elliott and Hari Hariharan and Ravinder Reddy",
year = "2013",
month = "8",
day = "15",
doi = "10.1016/j.neuroimage.2013.03.072",
language = "English",
volume = "77",
pages = "262--267",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Imaging of glutamate in the spinal cord using GluCEST

AU - Kogan, Feliks

AU - Singh, Anup

AU - Debrosse, Catherine

AU - Haris, Mohammad

AU - Cai, Kejia

AU - Nanga, Ravi Prakash

AU - Elliott, Mark

AU - Hariharan, Hari

AU - Reddy, Ravinder

PY - 2013/8/15

Y1 - 2013/8/15

N2 - Glutamate (Glu) is the most abundant excitatory neurotransmitter in the brain and spinal cord. The concentration of Glu is altered in a range of neurologic disorders that affect the spinal cord including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and spinal cord injury. Currently available magnetic resonance spectroscopy (MRS) methods for measuring Glu are limited to low spatial resolution, which makes it difficult to measure differences in gray and white matter glutamate. Recently, it has been shown that Glu exhibits a concentration dependent chemical exchange saturation transfer (CEST) effect between its amine (-NH2) group protons and bulk water protons (GluCEST). Here, we demonstrate the feasibility of imaging glutamate in the spinal cord at 7T using the GluCEST technique. Results from healthy human volunteers (N=7) showed a significantly higher (p<0.001) GluCESTasym from gray matter (6.6±0.3%) compared to white matter (4.8±0.4%). Potential overlap of CEST signals from other spinal cord metabolites with the observed GluCESTasym is discussed. This noninvasive approach potentially opens the way to image Glu in vivo in the spinal cord and to monitor its alteration in many disease conditions.

AB - Glutamate (Glu) is the most abundant excitatory neurotransmitter in the brain and spinal cord. The concentration of Glu is altered in a range of neurologic disorders that affect the spinal cord including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and spinal cord injury. Currently available magnetic resonance spectroscopy (MRS) methods for measuring Glu are limited to low spatial resolution, which makes it difficult to measure differences in gray and white matter glutamate. Recently, it has been shown that Glu exhibits a concentration dependent chemical exchange saturation transfer (CEST) effect between its amine (-NH2) group protons and bulk water protons (GluCEST). Here, we demonstrate the feasibility of imaging glutamate in the spinal cord at 7T using the GluCEST technique. Results from healthy human volunteers (N=7) showed a significantly higher (p<0.001) GluCESTasym from gray matter (6.6±0.3%) compared to white matter (4.8±0.4%). Potential overlap of CEST signals from other spinal cord metabolites with the observed GluCESTasym is discussed. This noninvasive approach potentially opens the way to image Glu in vivo in the spinal cord and to monitor its alteration in many disease conditions.

KW - Chemical exchange saturation transfer

KW - Glutamate

KW - MRI

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=84877019792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877019792&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2013.03.072

DO - 10.1016/j.neuroimage.2013.03.072

M3 - Article

VL - 77

SP - 262

EP - 267

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

ER -